Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients

Nutrition

Volumn 24, Issue 7-8, 2008, Pages 663-668

  Mimura, Érika C Mayumi ^a   Breganó, José Wander ^b   Dichi, Jane Bandeira ^c   Gregório, Emerson Pereira ^a   Dichi, Isaias ^c  

^a Hospital do Coracao de Londrina   (Brazil)

^b UNIVERSITY OF LONDRINA   (Brazil)

^c University Hospital of Londrina   (Brazil)

Author keywords

Ferrous glycinate chelate; Ferrous sulfate; Gastrectomy; Iron deficiency anemia

Indexed keywords

CHELATE; FERRITIN; FERROUS GLYCINATE CHELATE; FERROUS SULFATE; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GASTRECTOMY; GASTRITIS; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; MALE; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; STOMACH PH; TREATMENT OUTCOME;

AGED; ANEMIA, IRON-DEFICIENCY; BIOLOGICAL AVAILABILITY; FEMALE; FERRITINS; FERROUS COMPOUNDS; GASTRECTOMY; GLYCINE; HEMOGLOBINS; HUMANS; INTESTINAL ABSORPTION; IRON; IRON CHELATING AGENTS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; TREATMENT OUTCOME;

EID: 44749088199     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.03.017     Document Type: Article

References (26)

1. Harju E. Metabolic problems after gastric surgery. Int Surg 75 (1990) 27-35
2. Hines J.D., Hoffbrand A.V., and Mollin D.I. The hematologic complications following partial gastrectomy. Am J Med 43 (1967) 555-569
3. Meyer J.H. Nutritional outcomes of gastric surgery. Gastroenterol Clin North Am 23 (1994) 227-260
4. Bae J.M., Park J.W., Yang H.K., and Kim J.P. Nutritional status of gastric cancer patients after total gastrectomy. World J Surg 22 (1998) 254-261
5. Bragelmann R., Armbrecht U., Rosemeyer D., Schneider B., Zilly W., and Stockbrugger R.W. Nutrient malassimilation following total gastrectomy. Scand J Gastroenterol 218 Suppl (1996) 26-33
6. Papini-Berto S.J., Maio R., Módolo A.K., Santos M.D.B., Dichi I., and Burini R.B. Desnutrição protéico-energética no paciente gastrectomizado. Arq Gastroenterol 39 (2002) 3-10
7. Hunt G.C., and Faigel D.O. Endoscopic evaluation of patients with partial gastrectomy and iron deficiency. Dig Dis Sci 47 (2002) 641-644
8. Pineda O. Studies using iron bis-glycine chelate. Absorption, regulation and toxicity. In: Proceedings of the International Conference on Human Nutrition; Salt Lake City, Utah, USA. 1998; p. 24-5.
9. Layrisse M., Garcia-Casal M.N., Solano L., Baron M.A., Arguello F., Llovera D., et al. Iron bioavailability in humans from breakfasts enriched with iron bis-glycine chelate, phylates and polyphenols. J Nutr 130 (2000) 2195-2199
10. Olivares M., Pizarro F., Pineda O., Name J.J., Hertrampf E., and Walter T. Milk inhibits and ascorbic acid favors ferrous bis-glycine chelate bioavailability in humans. J Nutr 127 (1997) 1407-1411
11. Pineda O., Ashmead H.D., Perez J.M., and Lemus C.P. Effectiveness of iron amino acid chelate on the treatment of iron deficiency anemia in adolescents. J Appl Nutr 46 (1994) 2-13
12. Pizarro F., Olivares M., Hertrampf E., Mazariegos D., Arredondo M., Letelier A., and Gidi V. Iron bis-glycine chelate competes for the nonheme-iron absorption pathway. Am J Clin Nutr 76 (2002) 577-581
13. Hillman R.S. Hematopoietic agents: growth factors, minerals and vitamins. In: Hardman J.G., Limbird L.E., Molinoff P.B., Roddon R.D., et al. (Eds). Goodman and Gilman's pharmacological basis of therapeutics. 9th ed. (1996), McGraw-Hill, New York 1311-1340
14. Bovell-Benjamin A., Viteri F.E., and Allen L.H. Iron absorption from ferrous bisglycinate and ferric trisglycinate in whole maize is regulated by iron status. Am J Clin Nutr 71 (2000) 1563-1569
15. Iost C., Name J.J., Jeppsen R.B., and Ashmead H.D. Repleting hemoglobin in iron deficiency anemia in young children through liquid milk fortification with bioavailable iron amino acid chelate. J Am Coll Nutr 17 (1998) 187-194
16. Miglioranza L.H.S., Matsuo T., Caballero-Córdoba G.M., Dichi J.B., Cyrino E.S., Oliveira I.B.N., et al. Effect of long-term fortification of whey drink with ferrous bisglycinate on anemia prevalence in children and adolescents from deprived areas in Londrina, Paraná, Brazil. Nutrition 19 (2003) 419-421
17. Pineda O., and Ashmead H.D. Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate. Nutrition 17 (2001) 381-384
18. Magnusson B., Norrby A., Olbe L., Rehnberg O., Solvell L., and Swolin B. Hematological findings in patients 3-6 years after antrectomy with gastroduodenostomy. Scand J Haematol 26 Suppl (1976) 17-51
19. Schrumpf A., and Gjersten K. Serum B12 and serum iron after gastric surgery. Acta Med Scand 186 (1969) 561-564
20. Lloyd D.A., and Valberg L.S. Serum ferritin and body iron status after gastric operations. Dig Dis 22 (1977) 598-604
21. Silva L.F., Oliveira J.D., and Marchini J.S. Serum iron analysis of adults receiving three different iron compounds. Nutr Res 24 (2004) 603-611
22. Hacihanefioglu A., Edebali F., Celebi A., Karakaya T., Senturk O., and Hulagu S. Improvement of complete blood count in patients with iron deficiency anemia and Helicobacter pylori infection after the eradication of Helicobacter pylori. Hepatogastroenterology 51 (2004) 313-315
23. Sarker S.A., Davidsson L., Mahmud H., Walczyk T., Hurrell R.F., Gyr N., and Fuchs G.J. Helicobacter pylori infection, iron absorption, and gastric acid secretion in Bangladeshi children. Am J Clin Nutr 80 (2004) 149-153
24. Onoda N., Maeda K., Sawada T., Wakasa K., Arakawa T., and Chung K.H.Y.S. Prevalence of Helicobacter pylori infection in gastric remmant after distal gastrectomy for primary gastric cancer. Gastric Cancer 4 (2001) 87-92
25. Katsube T., Ogawa K., Hamaguchi K., Murayama M., Konnno S., Shimakawa T., et al. Prevalence of Helicobacter pylori in the residual stomach after gastrectomy after gastric cancer. Hepatogastroenterology 49 (2002) 128-132
26. Roviello F., Fotia G., Marrelli D., De Stefano A., Macchiarelli R., and Pinto E. Iron deficiency anemia after subtotal gastrectomy for gastric cancer. Hepatogastroenterology 51 (2004) 1510-1514